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What is already known about this topic?
•• Extensive clinical and ethical debate surrounds the practice of sedation for symptom palliation in end-of-life care, but is 
rarely informed by experiential accounts from clinicians who care for dying people.
•• Existing research, mainly survey based, shows that clinical practice with sedation in end-of-life care varies by country in spite 
of clear guidelines; the reasons for this are not understood.
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Abstract
Background: Extensive debate surrounds the practice of continuous sedation until death to control refractory symptoms in terminal 
cancer care. We examined reported practice of United Kingdom, Belgian and Dutch physicians and nurses.
Methods: Qualitative case studies using interviews.
Setting: Hospitals, the domestic home and hospices or palliative care units.
Participants: In all, 57 Physicians and 73 nurses involved in the care of 84 cancer patients.
Results: UK respondents reported a continuum of practice from the provision of low doses of sedatives to control terminal 
restlessness to rarely encountered deep sedation. In contrast, Belgian respondents predominantly described the use of deep sedation, 
emphasizing the importance of responding to the patient’s request. Dutch respondents emphasized making an official medical decision 
informed by the patient’s wish and establishing that a refractory symptom was present. Respondents employed rationales that showed 
different stances towards four key issues: the preservation of consciousness, concerns about the potential hastening of death, whether 
they perceived continuous sedation until death as an ‘alternative’ to euthanasia and whether they sought to follow guidelines or 
frameworks for practice.
Conclusion: This qualitative analysis suggests that there is systematic variation in end-of-life care sedation practice and its 
conceptualization in the United Kingdom, Belgium and the Netherlands.
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Introduction
Extensive debate surrounds the practice of palliative seda-
tion,1 which entails the deliberate lowering of conscious-
ness of a patient. Palliative sedation can be given in two 
ways: (1) short-term or intermittent sedation or (2) con-
tinuous sedation until death.2 Guidelines or frameworks 
for European practice recommend that the use of continu-
ous sedation until death for refractory symptoms giving 
rise to unbearable suffering should occur only when the 
patient’s disease is irreversible and advanced and that there 
should be no primary intent to hasten death.2–4 However, 
empirical studies suggest that the practice varies across a 
number of dimensions, including prognosis, whether suf-
fering is perceived as physical or existential,5 types of 
drugs used,6 depth7 and whether the patient has decisional 
capacity or has requested assisted dying.8 Physicians’ reli-
gious or ethical perspectives are associated with different 
practices.9–12 Existing evidence also suggests differences 
by country. A comparative secondary analysis of question-
naires sent to physicians in Belgium, the Netherlands and 
the United Kingdom13 found that ‘country’ predicted the 
probability of reporting use of ‘continuous deep sedation’, 
even when correcting for other variables. A qualitative 
study in the United States and the Netherlands showed that 
justifications for sedation differed.14 Furthermore, a small 
qualitative study15 found that Dutch and Belgian inter-
viewees positioned continuous sedation until death as an 
‘alternative’ to euthanasia, while UK interviewees placed 
emphasis on the medical management of symptoms. In 
2005, the Royal Dutch Medical Association published a 
guideline.16 A comparable guideline was published in 2012 
in Flanders, the Dutch-speaking region of Belgium.17 No 
national guideline exists in the United Kingdom.
In this article, we report results from the UNBIASED 
study (UK–Netherlands–Belgium International Sedation 
Study)18 to compare how physicians and nurses from 
these countries describe their practice and what rationales 
they use.
Participants and methods
Details of the methods employed are available elsewhere;18 
we provide a summary here. The study was approved by 
research ethics committees as follows:
United Kingdom: Leicestershire, Northampton and 
Rutland Research Ethics Committee 1, 10/H0406/57
Belgium: Ghent University Hospital Ethics Committee, 
B670201010174
Netherlands: Erasmus MC Medical Ethical Research 
Committee, NL33327.078.10, v03
Each participant gave written informed consent before 
taking part. We followed the Consolidated Criteria for 
Reporting Qualitative Research (COREQ) guidelines in 
reporting this study.19 Data collection took place between 
January 2011 and May 2012.
Study design
A qualitative case study design enabled exploration of a 
complex phenomenon from a variety of perspectives.20 
Each case comprised the physician, nurse and bereaved 
relative of an adult cancer patient who had received con-
tinuous sedation prior to death.
Settings
To enable maximum variation in the cases studied,21 we 
conducted the study in hospitals, the domestic home and 
hospices (United Kingdom and the Netherlands) or pallia-
tive care units attached to hospitals (Belgium).
Participants and inclusion criteria for decedents
Nurses and physicians were invited to take part if they had 
been closely involved in the care of patients aged over the 
age of 18 years who had died of cancer and to whom 
What does this paper add?
•• Continuous sedation at the end of life is practised and perceived differently by physicians and nurses in the United Kingdom, 
the Netherlands and Belgium.
•• Differences in practice can be explained by the different values and concerns that UK, Belgian and Dutch clinicians have with 
regard to consciousness during dying, hastening death, continuous sedation as an ‘alternative’ to euthanasia and using guide-
lines for practice.
Implications for practice, theory or policy
•• Our findings point to the need for greater understanding of different cultural and ethical perspectives on appropriate 
courses of action for the relief of suffering in the variety of challenging situations that clinicians are likely to face at the 
bedside.
•• Ethical dilemmas associated with sedation in end-of-life care can be usefully illuminated by carefully designed empirical stud-
ies enabling international comparisons.
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Table 1. Physicians’ and nurses’ characteristics.
Characteristics Physicians (n = 57) Nurses (n = 73)
Country UK (n = 17) BE (n = 18) NL (n = 22) UK (n = 25) BE (n = 20) NL (n = 28)
Age (years)
 <40 7 5 10 9 7 12
 40–50 6 6 3 8 7 7
 >50 4 6 9 5 5 9
 Not stated 0 1 0 3 1 0
Gender
 Male 8 9 12 0 3 2
 Female 9 9 10 25 17 25
Specialism
 Primary care 5 7 10 3 6 1
 Palliative home care team 0 2 0 4 5 8
 Hospital oncology ward* 4 2 3 2 5 9
  Palliative care unit/ 
hospice care
8 7 9 16 4 10
UK: United Kingdom; BE: Belgium; NL: The Netherlands.
sedating medications with the intention to decrease aware-
ness were administered continuously to alleviate other-
wise uncontrollable symptoms (either physical or 
psychological/existential), and for whom the sedation was 
in place at the time of death. Senior clinical staff identi-
fied eligible decedents and then nominated the physicians 
and nurses most involved in their care. Physicians and 
nurses were interviewed about no more than three patients. 
Interviews took place as soon as possible after death. In 
most cases, this was within 2 months.
Procedures
Interviews were semi-structured using an aide mémoire.18 
Interviews focused on recollections of the care of the dece-
dent, reasons for the use of sedation, its implementation 
and decision-making. Interviews were audio recorded, 
transcribed and translated as required. Recruitment to 
interviews commenced in January 2011 and was complete 
by May 2012.
Analysis
We wrote up the interviews attached to each decedent’s 
case into qualitative case studies. To aid rigour, for selected 
cases, this was done independently by two researchers 
from different countries,22 with cross-case comparison 
undertaken by exchange and study of different cases from 
different countries and care settings by the international 
research team. In addition, we undertook a thematic analy-
sis based on Strauss and Corbin’s constant comparative 
method23 to aid within-case analysis. We presented over-
views of findings to clinical audiences, including some 
study participants, in a process of respondent validation.22
Findings
We studied 84 patient cases (22 UK; 35 NL; 27 BE) involv-
ing interviews with 57 physicians (17 UK; 22 NL; 18 BE) 
and 73 nurses (25 UK; 28 NL; 20 BE). Table 1 gives char-
acteristics of the interviewees, showing that the majority 
(73 out of 130) were palliative or hospice care practition-
ers. Table 2 provides an overview of the characteristics of 
the patients and their care setting. Table 3 provides exam-
ples of the range of reasons described by participants for 
provision of continuous sedation until death. Some details 
have been omitted from the tables and subsequent presen-
tation of quotes to ensure concealment of patients’ identi-
ties. Some clinical information has been given where we 
judged that this would help readers understand the context 
of the quotes.
United Kingdom
The practice of continuous sedation until death as reported by 
UK physicians and nurses. UK respondents described a con-
tinuum of practice, from the provision of low doses of 
sedatives commonly given to patients to control terminal 
agitation or restlessness (referred to as ‘normal end of life 
care with sedation’ by one hospice physician) to the provi-
sion of continuous deep sedation in rare and highly memo-
rable situations where it was exceptionally challenging to 
bring suffering under control:
I think the Liverpool Care Pathway has been extremely 
helpful in highlighting that agitation at the end of life is 
relatively common and can be well treated and well managed, 
and the quality of end of life care that patients receive and 
families experience can be improved by recognising that as a 
symptom and treating it. And I would put that into the bracket 
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of, of relatively normal end of life care with, with sedation. 
There are some cases – and they, they stick in your mind and 
you’ll probably get a few of them in the study – where, you 
know, it taxes people enormously … to make sure that 
somebody isn’t distressed or agitated at the end of life. 
(Consultant physician, hospice 2, case 4)
So in the end we gave him some phenobarbitone and he 
needed three injections of 200 mg before he finally settled, but 
he died a few hours later. So we did settle him in the end, but 
it was unpleasant for everybody, and his wife had a very 
difficult time. I think she found it very hard, understandably 
… he had very resistant agitation is what I‘d say. So 
phenobarbitone’s not something we use very frequently and 
it’s something we use so infrequently that you think, ‘Oh my 
goodness, how do we use it?’ (Consultant physician, hospice 
1, case 7, reflecting on the care of a man who died of lung 
cancer and suffered extreme pain and distress)
Often, there was no intent reported for continuous seda-
tion, once started, to continue until death. UK respondents, 
especially nurses, described using sedatives to ensure that 
dying patients were ‘settled’ or ‘comfortable:
… our aim when we set out to start a syringe driver and make 
the changes to the syringe driver, was to see if we can get her 
settled. (Specialist registrar, hospice 2, case 1)
I don’t usually use the word ‘sedation’, I use the term ‘make 
him more comfortable and settled’. (Junior nurse, hospital 
case 3)
Being ‘settled’ or ‘comfortable’ was portrayed as being 
‘just rouseable’, akin to light sleep. Several physicians 
described sedation as a ‘side effect’ of managing difficult 
physical symptoms:
Actually what we’re aiming for is the kind of minimum 
amount of sedation needed to get symptoms under control … 
it may require regular medication along with extra doses and 
needing sort of quite, quite heavy doses of sedation, but, you 
know, the aim isn’t to sedate the aim is to relieve symptoms 
… we try very hard to give the medication for the symptom 
relief with a recognised side-effect that we’re trying to 
minimize. (Consultant physician, hospice 2, case 2, reflecting 
on the care of a man who died from metastatic cancer, with 
terminal agitation)
An example of this was when one junior doctor said that she 
did not give people continuous sedation but instead ‘medica-
tions to relieve agitation’, which had sedative side effects:
I haven’t given anybody continuous sedation; there have been 
lots of patients who have become agitated at the end of their 
lives and in those cases it’s appropriate to give medications to 
relieve that agitation and that restlessness, so we are giving 
drugs that do have sedative effects but the aim is not 
necessarily to sedate, the aim is to relieve that agitation and 
restlessness and make them more comfortable. (Junior doctor, 
hospice 1, case 4)
In the United Kingdom, normal practice was reported 
as entailing provision, usually at the nurse’s discretion, of 
low doses of ‘core’ sedative, anti-emetic and analgesic 
drugs to the patient in accordance with a prescription that 
had been written up by physicians in anticipation of symp-
toms which may occur. In the cases studied, there were no 
reports on the provision of clinically assisted hydration 
once continuous sedation was started, except for the deliv-
ery of medication:
We tend to give small doses; ‘prn’ to begin with, and then 
perhaps another one or two if that is not successful. But then 
we would move to a syringe driver, rather than going in and 
giving 5, 6, or 7 ‘prn’ doses a day. We can’t do that so we tend 
then to go to syringe driver, it makes it easier to manage a 
case. (Nurse, community, case 1)
I think this patient was only in [hospice] for, for less than two 
days – we always start with quite low doses; we always start 
Table 2. Characteristics of patients.
Cases (Belgium (n = 27), 
Netherlands (n = 35), United 
Kingdom (n = 22))
n = 84
Age (years)
 <40 6
 41–60 20
 61–80 45
 >80 11
 Unknown 2
Gender
 Male 43
 Female 41
Diagnosis
  Adenocarcinoma, 
peritoneal or sarcoma
5
 Abdominal/stomach 3
 Bladder/renal 7
 Colo-rectal 8
 Brain/glioblastoma 6
 Breast 5
 Gynaecological 4
 Oesophageal 1
 Gall bladder/pancreatic 7
  Leukaemia/myelofibrosis/
myeloma
4
 Lung/mesothelioma 16
 Melanoma 4
 Prostate 7
 Unknown primary 7
Care setting
 Home 30 (9 UK; 11 BE; 10 NL)
 Hospital 28 (4 UK; 10 BE; 14 NL)
  Palliative care unit (BE)/
hospice (UK/NL)
26 (9UK; 6 BE; 11 NL)
52 Palliative Medicine 29(1)
Table 3. Example of the range of reasons for using continuous sedation until death.
Refractory pain and/or delirium
‘… at night, with the change in how he coped, his character changed completely. He became aggressive; he became abusive and was 
not a man you could reason with, and we felt as though, as a team, we were chucking the cupboard at him and nothing was touching 
this pain. And we went through escalating doses of … well, the ketamine, we added in clonazepam, we added in other opiates, and 
we just didn’t seem to be getting anywhere. And this behaviour of non-coping and escalated pain then began to encroach into the 
day as well … And even that, with the doses of phenobarbitone that was the case, you know, it wasn’t a quick, easy solution’. (UK 
hospice nurse, case 7, reflecting on the care of a man who died of lung cancer, with extreme pain and distress)
‘It [sedation] was discussed with the family and [patient] because of the pain … Because the handling was extremely painful’. 
(Belgian general practitioner, case 1, reflecting on the care of woman with cancer and a hip fracture, who died at home and suffered 
extreme pain from her hip fracture)
‘… she indeed became increasingly confused, painful, without the actual possibility of adequate medical therapy anymore’. 
(Netherlands, hospital physician, case 1, reflecting on the care of a woman with refractory pain and generalized extreme distress)
‘… there was a lot of confusion, a lot of agitation and the doctor who was looking after him sort of ran to the bay with the nurses 
and tried to calm him down. He was very aggressively agitated’. (UK junior hospital doctor, case 3, reflecting on the care of an 
elderly man who died in hospital with cerebral metastases)
Responding to a patient’s request for relief from pain
‘… And I discussed that, yes, that was an option for her to be put to sleep [to] make you feel comfortable [so] that she would not 
feel the pain’. (Belgian oncologist, case 17, reflecting on the care of an elderly woman with pancreatic cancer, who died in hospital)
Refractory nausea and vomiting
‘… the medicines he was having to control his sickness, it wasn’t controlling it. It was, it was breaking through. I’d say after three, 
maybe four days, it was starting to present itself and it was pretty bad’. (UK general practitioner, case 1, reflecting on the care of an 
elderly man who died at home with gallbladder cancer)
‘… Thursday night he started vomiting blood, and he was, at that moment he was conscious and approachable and vomiting blood 
and we had to give extra [sedative] medication against the vomiting’ (Belgian general practitioner, case 9, reflecting on the care of a 
man who died at home with metastatic cancer)
Refractory dyspnoea
‘… on Monday morning he was still there, but, he was very miserable so I then decided; I going to sedate him because it wasn’t 
really possible anymore’.
I: And how do you mean miserable?
‘Miserable, he was gasping like a fish out of water even with maximum oxygen, soaked in sweat and stressed … Terrified, couldn’t 
get comfortable and could barely talk’. (Netherlands oncologist, case 12, reflecting on the care of a young man with metastatic 
cancer who died in hospital)
‘… A combination of dyspnoea, pain, confusion and clear clinical deterioration for which you have exhausted all possibilities to fix it 
with medication’. (Netherlands, hospital physician, case 2, reflecting on the care of a man who died of sarcoma)
Existential suffering
‘The man was above all, actually had a lot of existential problems. That was someone who belonged on the palliative unit but at 
that time there was no place there. That man actually asked to be left alone and [for] peace in the last days of his life …’ (Belgian 
oncologist, case 18, reflecting on the care of elderly man who died in hospital)
in a cautious way and sometimes when you do that, people 
need another dose and then another dose and then an escalation 
in the dose in their syringe driver, because you’ve started 
cautiously and built up rather than starting with a high dose 
and then, and completely flattening somebody at the outset, 
and that can sometimes be difficult. I think it’s, these sorts of 
cases are ones where the patient needs regular review and the 
family need to know that that’s the intention, to review 
regularly and to be able to give an extra dose if necessary. 
(Consultant physician, hospice 2, case 4, reflecting on the 
care of a woman who died from glioblastoma, which he said 
typified normal practice with sedation)
Reported rationales for practice. Four factors provided a 
rationale for the practice as reported by UK practitioners. 
First, many UK respondents were anxious that the use of 
‘heavy’ doses of sedative may hasten death or be seen to be 
equivalent to euthanasia. This was notably present among 
nurses, and less so among hospice consultants. Dilemmas 
were perceived to be posed by patients who requested 
assisted dying; hospice respondents reported that this 
sometimes occurred in patients with very high symptom 
burdens:
So I know our tendency is to start small because people worry 
about it and they worry that people will suddenly be sedated 
and people will assume that’s what’s killing them … And 
even in hindsight thinking, ‘Would I have done it differently?’, 
talking to my team they all said, ‘But [nurse’s name] we 
always start small’. (Specialist palliative care nurse, hospital, 
case 1, reflecting on difficult death of a man from lung cancer, 
with uncontrolled symptoms)
Second, UK physicians and nurses sought to ensure that 
patients could maintain interaction for as long as possible, 
while seeking to provide enough sedation to ensure that 
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patients became ‘settled’ and ‘comfortable’. Some respond-
ents considered it to be morally wrong to decrease or 
remove a patient’s consciousness:
He was needing to have quite a lot of extra doses in that last 
period, and there’s, there is a sense that you don’t want to 
over-sedate people … looking back at that … I think I might 
have put a bit more in the driver considering he was already 
on quite a lot of oral or, you know, peg diazepam. But I think 
staff have a real concern they don’t over-sedate people 
because they don’t want to be seen to be knocking them out. I 
guess when you’re looking at how much you sedate people, 
it’s important to be proportionate; it’s also important to be 
effective. (Consultant physician, hospice 1, case 3, reflecting 
on the care of a man who died with difficult symptoms and 
who requested sedation)
… we’re probably a little bit more cautious in general practice 
in terms of how we, how we start it. And, and that might be to 
the detriment of the patient at times, I wonder. (General 
physician, community, case 3)
… we want them to be comfortable but we don’t want to 
totally knock them out and not have interaction with their 
family; and the family is quite happy to see him comfy, 
settled. (Junior nurse, hospital, case 3)
Third, commencement of the Liverpool Care Pathway 
was reported to be a signal to activate an anticipatory pre-
scription (sometimes referred to as ‘just in case’ prescrip-
tions), including the use of sedative drugs:
… when we start the Liverpool Care Pathway at the end of life 
– the end of life drugs that are prescribed anyway in case all 
these symptoms associated with dying come up – and if we 
feel, like the nurses feel that my patient is getting agitated or 
is in a lot of pain, we can just go ahead and give it. And they 
always prescribe like a range starting from the lower to the 
upper limit so we just sort of titrate and go up as, you know, 
how much your patient needs or how agitated they’re getting. 
(Nurse, hospice 1, case 4)
Fourth, respondents were concerned to ensure that they 
balanced the perspectives of patients, families and their 
colleagues when deciding how to manage a patient’s dis-
tress. This was especially noticeable in the 5 out of 22 
cases studied where patients had what one respondent 
described as ‘resistant agitation’ (see Table 3):
How do you do something to a patient, even if it’s what we 
want, that the family are saying you mustn’t do? And the 
books say: competent patient, ignore the family, do what the 
competent patient wants … I mean the books would say he 
was competent and we were all clear, the psychiatrist was 
clear, he wasn’t depressed, he was competent, he wanted to be 
asleep, we’d tried everything else … but how do you sedate 
someone fully when the wife is saying, ‘Don’t do it’. I don’t 
know. (Consultant physician, hospice 1, case 1, reflecting on 
the care of a man whose wife was unhappy about the use of 
sedation)
I go and say [to the family], ‘It’s we who made the decision, 
and not I who made the decision’, so, and that gives more 
strength saying it’s me as a part of the team’.(Specialist 
registrar, hospice 2, case 1)
I would still always ring the out-of-hours GPs even though it’s 
[drugs are] written up, and discuss it and you’ll find that the 
out-of-hours doctors are, you know, some will either come out 
or discuss it over the telephone with you and be happy to, to 
go on your clinical judgement. But, yeah, I think it’s got to be 
a team decision’. (GP, community case 8)
Belgium
The practice of continuous sedation until death as reported by 
Belgian physicians and nurses. In Belgium, there was a vari-
ety of patterns in respondents’ accounts. The predominant 
pattern was to seek to relieve patients’ suffering by estab-
lishing deep sedation either by starting with low doses of 
sedatives and then increasing these quickly, or by the pro-
vision of high dosages from the outset:
The aim of sedation is really to get someone fully sedated. 
As I said, we had a discussion about this on a daily basis 
with the palliative team and then it was switching to 
barbiturates, which was something we would have done, 
well, if I had estimated that it would still have taken a few 
days, we would certainly have done that … In retrospect you 
could say, maybe we should have switched from Dormicum 
[midazalom] to other products a day earlier. (GP, community 
case 9, reflecting on the care of a man who died with 
metastatic cancer)
I know in the beginning, uh, the first day she wasn’t really 
asleep. Then I did get back in contact with [Palliative Home 
Care Nurse Association] and then the medication was 
increased … normally speaking they enter a deep sleep fairly 
quickly they, but that actually wasn’t the case with her, 
although she wasn’t in pain
I: So first it was too low and then it was increased?
And then she was actually in a deep sleep, yes. (Nurse, 
community case 4)
We used the Pentothal to deepen the sleep of the man and he 
died the next day at 21.00 o’clock … we never give fluids or 
nutrition … we always stop in time, preferably before we start 
with the sedation, but at the time of sedation. Then we 
basically stop everything, because you want to support a 
natural dying process, or initiate it as was done here. 
(Physician, palliative care unit, case 5, describing continuous 
deep sedation over 8 days, with an anaesthetic agent used on 
day 7, in the management of a man who was reported to have 
lost the will to live)
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In the few examples where it was reported that patients 
had lost capacity, no such attempt to induce deep sedation 
was described. Instead, sedation was described as ‘medical 
decision’; for example, in one case, a general physician 
(GP) described it as an ‘acute medical help’ for refractory 
dyspnoea in his recollections of caring for a patient with 
lung cancer:
[We] eventually administered sedating medications and then 
they started at a dose which offered relative certainty that she 
would be calm. … So in fact there we did not have a deep 
sedation; there was no request from her and there wasn’t 
really a request from the family … it was decided to proceed 
to sedation, but rather in relation to the symptom. (Physician, 
palliative care unit, case 6, reflecting on the care of a woman 
who died from a glioblastoma)
And at that moment I thought yes, this guy is too scared now 
to rationally decide for himself and I need to intervene. So I 
took the family outside to discuss the matter with them, they 
had been sitting with him for the past 72 hours with a scared 
look on their faces and I said ‘look I will intervene for his own 
good and put him to sleep because he is too afraid to say yes 
now’ … the family agreed and was also glad that I had 
suggested it. … So I started with the dose he needed at [the 
previous night]. I always start with a dose of one mg per hour 
and every hour I get the nurses to evaluate how it’s going and 
increase it, for me. When they are sleeping peacefully, then 
they freeze the dose. (Oncologist, hospital oncology unit, case 
12, reflecting on the care of a young man with refractory 
dyspnoea)
It was reported to be usual practice to withdraw or with-
hold clinically assisted nutrition and/or hydration as soon 
as continuous sedation until death started, unless a patient 
had made a specific request to receive hydration. Belgian 
nurses reported a variety of responsibilities with regard to 
their role, from the provision of advice to GPs, to carrying 
out physicians’ instructions. Belgian respondents made a 
variety of references to guidelines and protocols: some 
relied on experience; others reported consultation with 
local palliative care specialists. A few made reference to 
Dutch guidelines:
I don’t know if they have something like that in the department 
here, or if an actual protocol was written, but I’ve always – I 
have my own standards. (Oncologist, hospital oncology unit, 
case 16)
No, only a consultation with the palliative network. (GP, 
community, case 1)
We must follow the instructions of the doctor … because we 
always depend on the doctors to start the treatments. (Nurse, 
community, case 1)
No. I have taken a course in palliative care, but no guidelines 
were ever mentioned. (GP, community, case 2)
I have the protocol … that is the protocol from the Netherlands 
… yes I also used these guidelines with this case. This is also 
in my doctor’s bag – the guidelines from the KNMG. (GP, 
community, case 25)
Reported rationales for practice. Three factors could be 
identified that provide a rationale for the practice reported 
by Belgian practitioners. First, most wanted to prevent 
patients coming to consciousness once sedation had been 
started and sought to sustain ‘deep sleep’ until death:
In principle it is the intention, if we sedate, that they really are 
well asleep because it is often confusing for the family that 
waking and sleeping, often … the family no longer expects 
that either and often when they are awake, they are still a bit 
restless and … ‘Gosh am I still here and …’ So I don’t find that 
necessary. Palliative sedation, I do prefer that they really are 
fully sedated. (Oncologist, hospital oncology unit, case 18)
Second and closely linked to the first was the perceived 
importance of honouring patients’ requests to be ‘taken out 
of suffering’ or to be ‘put to sleep’:
I just clearly said ‘look I am willing to do that if you want, 
we’ve talked about it, we’ve discussed it with you … it is you 
who decides. (GP, community, case 4)
He then came to the unit and said ‘I want to die like my wife’. 
So, for him it was rather more of an existential question really. 
He wanted to die as his wife had. The symptoms that were 
bothering him or encouraged him to determine the time or 
moment was due to being bedridden, having decreased 
mobility and pain, the man had many symptoms such as chest 
pain caused by the illness that he had. It was also his fear of 
pain that actually helped him decide, despite the fact that it 
felt like we had his pain quite well under control. However, it 
was mainly the fear.
I: So, the fear of future pain?
The fear of future pain, especially the fear of future pain, the 
decay process and the ‘being done’. (Physician, palliative 
care unit, case 5)
Third, a predominant emphasis (in 18 of 25 cases) was 
the description of continuous sedation until death and 
euthanasia as ‘alternatives’ with discussions with patients 
and their families reported about these ‘options’. In five 
cases, physicians reported using continuous sedation until 
death for patients who had requested euthanasia but then 
become incompetent before they were either able to com-
plete the formal process or discuss their wish with their 
family. In the other cases studied, continuous sedation was 
preferred by the physician over the possible ‘choice’ of 
euthanasia for moral reasons, or because patients preferred 
continuous sedation. Respondents accepted that continu-
ous sedation until death may hasten death where it extended 
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over several days, although most said this was not their 
primary intention. In two cases, palliative care unit physi-
cians described an explicit life-shortening intent:
… we have had, yes, a very open conversation once she 
indicated that she wanted to put an end to it. So we listed the 
various options available so ranging from – from actually 
waiting until it being spontaneous, to euthanasia – and, as an 
alternative, palliative sedation. (Oncologist, hospital oncology 
unit, case 20)
I should have had the conversation about euthanasia in the 
beginning, because that was perhaps a better option [but] 
there is a group where perhaps palliative sedation is a more 
appropriate option because euthanasia is out of the question 
for them. So I see them as complementary. (GP, community, 
case 25)
It’s not a coincidence that eventually euthanasia is being done 
a lot less frequently than sedation, because somehow … 
sedation is considered to be more naturally and it’s also more 
in line with what the natural process brings: more sleep. 
(Physician, palliative care unit, case 26)
With the intention of, with sedation, but not to take too long. 
From a … to have a shortening effect. I’m honest about that. I 
think that is okay, given the euthanasia desire, so, yes, it’s, yes, 
I would rather say a sedation but surely in the direction of a 
slow euthanasia. (Oncologist, hospital oncology unit, case 23)
The Netherlands
The practice of continuous sedation until death as reported by 
Dutch physicians and nurses. Dutch physicians and nurses 
typically reported using sedation where a refractory symp-
tom was present and a patient was in the last days of life. 
They talked about making a ‘formal’ medical decision fol-
lowing discussion with the patient and/or their family and 
with colleagues:
… then in the course of the morning, there were talks and in 
the afternoon we officially started with sedation … Well, the 
doctor explained to them [family] the details of how it works 
and what it means, that there is no more contact possible with 
the patient. (Hospital nurse, case 1)
[The doctor] was just like: first I’m going to give that shot of 
Dormicum [midazalom], then we will immediately check the 
protocol and then I’ll connect the pump. So I think that’s how 
it happened … And yes that’s a whole protocol of how you are 
going to start, with what dosage you give the first shot and 
how you proceed with the sedation … Yes, that all happened 
very officially. (Hospital nurse, case 8)
Usual practice was described as involving starting with 
low doses of sedative and then cautiously increasing the 
dosage until the patient was in a quiet and peaceful state. 
Once sedation was started, artificial hydration was usually 
reported to be withdrawn or withheld. In most cases, 
nurses described having responsibility for carrying out the 
doctor’s instructions, monitoring the response of the 
patient to the sedatives once started and, if required, 
increasing the dosages according to medical instruction:
Yes, if people, if the family, or us, nurses or doctors feel that 
the patient is still a bit restless, then the dosage is increased … 
But thus far, from what I’ve experienced a large increase is 
rarely needed. (Hospital physician, case 1)
So look, you’re trying to get the situation under control again, 
you try to create peace and it’s not about injecting someone 
out of this world, you just want the situation to be calm again. 
For the patient, for the relatives. But you do not want too 
much. (Hospital nurse, case 4, reporting on the care of a 
patient with cerebral metastases)
With the dose that we give we always try to start with the lowest 
dose, so we don’t force anything … we just start according to 
the guideline, low. (Hospice physician, case 21)
Reported rationales for practice. In the Netherlands, the 
presence of the national palliative sedation guideline 
framed most respondents’ reports. For example, the man-
ner of titration of medications was described to be pre-
scribed by the guideline. Terms related to key indications 
for continuous sedation in the guidelines were used fre-
quently by the respondents, such as ‘refractory suffering’. 
However, several Dutch physicians reported that they 
found it sometimes necessary to ‘work round’ the guide-
line to meet patients’ needs, especially when suffering was 
perceived to be neither wholly physical nor refractory:
… we have a protocol for sedation, which is of course approved 
through the KNMG [Koninklijke Maatschappij ter bevordering 
van de Geneeskunde – Royal Dutch Medical Association], 
which is used nationwide. (Hospital nurse, case 4)
Yes you must do this according to the protocol. Of course 
you need to have good communication with family, doctors 
and nurses and be on the same wavelength. (Hospital nurse, 
case 8)
We definitely follow the rules when it comes to sedation. So 
the prognosis has to be less than two weeks, with refractory 
symptoms. And sometimes I think that we have to wait too 
long for that … So when she got the itch that we could do 
nothing about I thought hooray, we have a refractory symptom, 
now we can do sedation … (Hospital physician, case 3, 
reflecting on the care of a woman with renal cancer)
Second, while some Dutch respondents talked about 
continuous sedation and euthanasia as ‘alternatives’, oth-
ers made a clear distinction. It was explained that contrary 
to euthanasia: that first, sedation is a natural death, neither 
directly contributing to death nor hastening it:
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So it’s basically just nature doing her job. So in that respect 
it’s not actively contributing to death. Only in the way that 
everything else stops completely, the intake of fluids … Of 
course that can indirectly hasten death, but it is not an active 
termination … [in] euthanasia we often indicate that it has to 
be a longer process and that someone has to indeed be 
completely lucid … [the options discussed were] euthanasia, 
sedation or the natural way. Well, sedation is the natural way 
with a lot of symptom control. (Hospital physician, case 2, 
reflecting on the care of man who died of sarcoma)
Second, it was explained that sedation controls refrac-
tory symptoms when the requirements for euthanasia can-
not be met (such as lack of capacity or too little time to 
consult a second physician), and third, it was explained 
that the use of sedation is primarily a medical decision:
Yes, the psychiatrist, the ward doctor, and then yes the nurse 
who cared for her. And well yes, Mrs. X and her husband were 
probably also involved in the decision … it is in principle a 
decision that the doctor in consultation with the patient … and 
then the nurse … And the ward doctor consults [about] that 
with the supervisor. (Hospital nurse, case 3)
Quote 11: That first discussion was the most important, it took 
place on [date]; at that time we considered the options. 
Choices were made then. I am a general practitioner who 
prefers to work with palliative sedation. I do have some 
difficulty with euthanasia.
I:  And what did he think of this? Did you also dis-
cuss euthanasia at this time?
R: Yes of course we discussed it.
I: And what did he think of this?
R:  Initially, he thought that euthanasia would be a 
good solution. But when I explained the method 
of palliative sedation to him, he said he would 
like to have this too. Then the decision is not dif-
ficult for me to make. So finally, after a really 
thorough discussion we decided on palliative 
sedation. And that’s the way it goes. I admit that 
my guidance played some part in the decision … 
The decision is mine, and I wish to emphasize 
this fact to people – this is another thing that goes 
with palliative sedation. I have said that the deci-
sion is mine to make because palliative sedation 
cannot be administered in every situation. (GP, 
Case 11: reflecting on the care of man who died 
of lung cancer).
Some interviewees welcomed a quick death once seda-
tion had been started and a minority pattern of perception 
was that sedation does hasten death:
Yes, what you do read and hear is that people do not die 
sooner because of palliative sedation; I don’t believe any of it. 
That doesn’t correspond with my practical experience; it 
almost always goes incredibly fast. (GP, case 12)
… it increases the process of death … so I definitely think that 
it plays a role. (GP, case 15)
The third rationalizing factor was the need to ensure 
that once sedation was commenced, the patient did not 
come to awareness so that suffering was avoided:
Yes, deep sedation, really a dormant state, a body which is at 
rest and so is a little relaxed. And the moment that you are 
going to turn them, that there is no response. (Hospital nurse, 
case 4)
And so of course it had to be done well, because I could not 
have it that she would still wake up or that something else 
would happen and that I was not there. Then the pump would 
immediately need to go up, because she had to remain 
comfortable. (Hospital physician, case 10)
Discussion
This exploratory study of the use of continuous sedation 
until death for cancer patients has shown that UK respond-
ents report a continuum of practice from the provision of 
low doses of sedatives to control terminal restlessness to 
rarely used continuous deep sedation. In contrast, Belgian 
respondents predominantly describe the use of deep seda-
tion, emphasizing the importance of responding to the 
patient’s request for relief of suffering. Dutch respondents 
place emphasis on the making of an official medical deci-
sion informed by the patient’s wish where this is known 
and establishing that a refractory symptom was present 
before commencing sedation. Respondents employed 
rationales that showed different stances and values 
towards four key issues in the three countries. The first 
issue involved the preservation of consciousness. UK 
respondents sought to maintain patients in a ‘settled’ but 
‘just rouseable’ state. This gave raise to their descriptions 
of sedation as a ‘side effect’. In contrast, Belgian practi-
tioners reported the need to ensure that patients ‘stayed 
asleep’, focusing on honouring the choice of a patient 
who asked for sedation. A more mixed picture with regard 
to consciousness was observed in the Dutch accounts, 
although most set a similar value on ‘staying asleep’. 
There has been comparatively little attention to the values 
placed on consciousness in previous research, although 
quantitative studies reveal contradictory stances both 
within physician samples and between countries.9 Our 
findings resonate with the results of a Japanese survey, 
which found that continuous sedation was more frequently 
performed by physicians who did not believe conscious-
ness was necessary for a good death.24 A qualitative study 
of Dutch physicians showed that depth of sedation varied 
according to whether physicians placed emphasis on the 
duty to relieve suffering or the duty to observe the patient’s 
response to medication.7 Our finding that UK physicians 
referred to sedation as a ‘side effect’ resonates with results 
from a survey of US physicians where 85% agreed that 
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unconsciousness is an acceptable side effect of palliative 
sedation mirroring language in US guidelines.25
The second key difference concerned perspectives 
towards hastening death. Although there is a body of evi-
dence showing that where sedation is performed correctly, 
it does not hasten death,26 interviewees took variable posi-
tions towards this. UK practitioners thought hastening 
death may be a possible result of the use of continuous 
sedation and wanted to avoid this; findings that are similar 
to those from a study of Australian palliative care special-
ists.27 In contrast, some Belgian physicians accepted that 
continuous sedation may hasten death and in two cases 
reported a life-shortening intent. In the Netherlands, most 
practitioners did not perceive that sedation hastened death, 
and they tended to describe continuous sedation as ena-
bling a ‘natural’ death.28
A third difference centred on whether continuous seda-
tion until death could be an alternative to euthanasia. There 
was little mention of euthanasia by UK respondents; 
clearly, this will have been influenced by the fact that there 
has been no legalization of euthanasia in the United 
Kingdom. In contrast, most Belgian respondents perceived 
continuous sedation until death and euthanasia to be ‘alter-
natives’ which could be chosen by patients. This percep-
tion appeared less strongly in the Dutch accounts; although 
Dutch clinicians sometimes reported discussing the 
‘option’ of continuous sedation until death with patients, 
this was usually in situations where euthanasia had been 
talked about at an earlier point but could not be carried out 
at the time of the appearance of refractory suffering. While 
the European Association for Palliative Care has issued an 
ethical statement distinguishing between the two prac-
tices,29 our data suggest that the perceptions of practition-
ers working in countries where euthanasia has been 
legalized suggests they take a different view; this needs 
further attention in future research.
Fourth, the degree to which reports of practice were 
shaped by the presence or absence of guidelines was nota-
ble. Dutch respondents referred very frequently to the 
‘official’ recommendations in a national guideline which 
has legal ramifications, while reference to guidelines in the 
Belgian accounts was much more variable. Among UK 
respondents, especially those in non-hospice settings, the 
commencement of the Liverpool Care Pathway was 
regarded as a permissive ‘signal’ for use of low doses of 
‘core’ drugs including sedatives where the patient started 
to exhibit signs of agitation. Previous Dutch research sug-
gests that practice has changed towards compliance in the 
Netherlands since the publication of the national guideline, 
although there remains variety in symptom directed treat-
ment and some concerns about life-shortening conse-
quences of sedation.30 Existing research in Belgium 
resonates with our findings, suggesting that Belgian physi-
cians tend to be unfamiliar with existing recommendations 
and engage in variety of practices when using sedation in 
end-of-life care, including life-shortening intent, that are 
out of step with the latter.31,32 There is no rigorous research 
about the relationship between the Liverpool Care Pathway 
and sedation practice, although audit data exist.33
Strengths and limitations
The validity of this study was increased by purposively 
sampling physicians and nurses from three different care 
settings who had been closely involved in the end-of-life 
care of decedents identified using standardized criteria. 
However, this study has a number of limitations. Our 
interview data are dependent on the subjective experi-
ence and interpretation. Although our retrospective 
design does not preclude recall bias, this was limited in 
most of the cases by minimizing the time between the 
patient’s death and the interview with the practitioners to 
2 months. Further validation of our findings requires 
study of their resonance with other clinicians involved in 
the care of dying patients.
Conclusion
Our findings point to the need for greater understanding 
of different cultural and ethical perspectives on appropri-
ate courses of action for the relief of suffering in the vari-
ety of challenging situations that clinicians are likely to 
face at the bedside. Recognizing that practice is situated 
in different legal contexts, values and histories associated 
with palliative and end-of-life care may inform what are 
frequently contentious discussions about practice and pol-
icy in sedation.
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